Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine

J Infect Dis. 2018 Mar 13;217(7):1055-1059. doi: 10.1093/infdis/jix653.

Abstract

We studied the relationship between varicella-zoster virus (VZV) DNAemia and development of VZV-specific immunity after administration of live-attenuated zoster vaccine. VZV-DNAemia, detected by polymerase chain reaction (PCR), and VZV-specific effector (Teff) and memory (Tmem) T cells, was measured in 67 vaccinees. PCR was positive in 56% (9 direct, 28 nested) on day 1 and in 16% (1 direct, 10 nested) on day 14. Teff progressively increased in direct-PCR-positive vaccinees up to day 30, but Tmem did not. Conversely, Tmem, but not Teff, increased in direct-PCR-negative vaccinees on day 7. The kinetics of these immune responses and VZV DNAemia suggested that direct-PCR sample positive represented viremia.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Viral / blood
  • DNA, Viral / blood*
  • Herpes Zoster / blood
  • Herpes Zoster / prevention & control*
  • Herpes Zoster / virology
  • Herpes Zoster Vaccine / genetics
  • Herpes Zoster Vaccine / immunology*
  • Herpesvirus 3, Human / genetics*
  • Herpesvirus 3, Human / immunology
  • Humans
  • T-Lymphocytes / physiology
  • Vaccines, Attenuated / genetics
  • Vaccines, Attenuated / immunology
  • Viremia

Substances

  • Antibodies, Viral
  • DNA, Viral
  • Herpes Zoster Vaccine
  • Vaccines, Attenuated